 | Arcturus Therapeutics Holdings | |||
| NGM : ARCT || Location: United States | ||||
$26.59+0.42 (+1.6%) |
0.09 M | 25.84 - 26.84 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 4.613 M |
| March 28, 2024 | 4.810 M |
| March 15, 2024 | 4.206 M |
| Feb. 29, 2024 | 4.219 M |
| Feb. 15, 2024 | 4.521 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.01 | -0.32 | 68.38% |
| 09/30/2023 | -1.73 | -0.61 | 64.65% |
| 06/30/2023 | -0.22 | -1.98 | -820.93% |
| 03/31/2023 | 0.06 | 1.87 | 2970.61% |
| 12/31/2022 | 1.00 | 4.43 | 343.80% |
ARCT Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 26.915M | Shares Float | 24.550M |
| Short Float | 4.613M | Market Cap | 704.37M |
| Institution ownership | 90.55% | Insider ownership | 8.748% |
| Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.12 | Forward EPS | 0.22 |